Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Hepatitis

  Free Subscription


Articles published in Gastroenterol Hepatol

Retrieve available abstracts of 57 articles:
HTML format



Single Articles


    June 2021
  1. TURNES J, Rincon D, Calleja JL, Delgado MB, et al
    Non-pharmacologic direct cost of a simplified strategy with glecaprevir/pibrentasvir for 8 weeks in naive non-cirrhotic patients with hepatitis C implemented in clinical practice. The Just SIMPLE Study.
    Gastroenterol Hepatol. 2021 Jun 12. pii: S0210-5705(21)00198.
    PubMed     Abstract available


    May 2021
  2. REYGOSA C, Arraez DM, Hernandez-Bustabad A, Baute LM, et al
    Hepatitis C-Treated Patients As A Potential Source For Referral Of New Cases.
    Gastroenterol Hepatol. 2021 May 20. pii: S0210-5705(21)00148.
    PubMed     Abstract available


    April 2021
  3. BUSTA NISTAL MR, Garcia Sanchez MC, Mora Cuadrado N, Dura Gil M, et al
    Cholestatic hepatitis as a presentation of secondary syphilis.
    Gastroenterol Hepatol. 2021 Apr 16. pii: S0210-5705(21)00117.
    PubMed    


  4. COSTA CA, Garcia JLR, Gandia MAR, Martos RF, et al
    FULMINANT LIVER FAILURE DUE TO HEPATITIS B REACTIVATION DURING THE COVID-19 PANDEMIC.
    Gastroenterol Hepatol. 2021 Apr 13. pii: S0210-5705(21)00118.
    PubMed    


    November 2020
  5. ABIA PL, Sabater AM, Delgado SM, Haym MCB, et al
    Heat stroke and fulminant hepatitis: conservative management or liver transplant?
    Gastroenterol Hepatol. 2020 Nov 27. pii: S0210-5705(20)30435.
    PubMed    


  6. BARTRES C, Soy G, Forns X
    Hepatitis C therapy and anticonvulsants.
    Gastroenterol Hepatol. 2020 Nov 27. pii: S0210-5705(20)30432.
    PubMed    


  7. CRESPO J
    Screening guide for HCV infection in Spain.
    Gastroenterol Hepatol. 2020 Nov 19. pii: S0210-5705(20)30430.
    PubMed    


  8. GUTIERREZ GARCIA ML, Gomez Perosanz R, Acedo Sanz JM, Delgado-Iribarren Garcia-Campero A, et al
    Coordinated assistance plan for the elimination of hepatitis C virus at the centro de ayuda integral al drogodependiente (CAID (Comprehensive Care Centre for Drug Addicts)).
    Gastroenterol Hepatol. 2020 Nov 5. pii: S0210-5705(20)30315.
    PubMed     Abstract available


    October 2020
  9. MUNOZ-CODOCEO C, Amo M, Martin A, Martin-Arriscado Arroba C, et al
    Diagnostic accuracy of liver and spleen stiffness measured by fibroscan(R) in the prediction of esophageal varices in HCV-related cirrhosis patients treated with oral antivirals.
    Gastroenterol Hepatol. 2020 Oct 20. pii: S0210-5705(20)30321.
    PubMed     Abstract available


  10. YOZGAT A, Can G, Can H, Ekmen N, et al
    Social stigmatization in Turkish patients with chronic hepatitis B and C.
    Gastroenterol Hepatol. 2020 Oct 20. pii: S0210-5705(20)30366.
    PubMed     Abstract available


  11. LAGUNO CENTENO M, Alvarez B, Martinez-Rebollar M, de la Mora L, et al
    Efficacy of Elbasvir/Grazoprevir in Early Chronic G1/G4 Hepatitis C infection in HIV/HCV co-infected patients with mild fibrosis.
    Gastroenterol Hepatol. 2020 Oct 8. pii: S0210-5705(20)30280.
    PubMed     Abstract available


  12. TELLEZ L, Martin Mateos RM
    COVID-19 and liver disease: An update.
    Gastroenterol Hepatol. 2020;43:472-480.
    PubMed     Abstract available


    September 2020
  13. YANG Q, Zhong Z, Yang Y, Ma Y, et al
    Efficacy and Safety of Tenofovir in the Prevention of Perinatal Transmission of Hepatitis B, a Meta-Analysis.
    Gastroenterol Hepatol. 2020 Sep 15. pii: S0210-5705(20)30226.
    PubMed     Abstract available


  14. ZHANG ZQ, Shi BS, Lu W, Liu DP, et al
    Quantitative HBcrAg and HBcAb versus HBsAg and HBV DNA in predicting liver fibrosis levels of chronic hepatitis B patients.
    Gastroenterol Hepatol. 2020 Sep 10. pii: S0210-5705(20)30231.
    PubMed     Abstract available


    August 2020
  15. RODRIGUEZ M, Buti M, Esteban R, Lens S, et al
    Consensus document of the Spanish Association for Study of the Liver on the treatment of hepatitis B virus infection (2020).
    Gastroenterol Hepatol. 2020 Aug 7. pii: S0210-5705(20)30158.
    PubMed     Abstract available


    July 2020
  16. RIADO MINGUEZ D, Gutierrez Garcia ML, Fernandez Rodriguez C
    Chronic autoimmune hepatitis triggered by olmesartan.
    Gastroenterol Hepatol. 2020 Jul 13. pii: S0210-5705(20)30232.
    PubMed    


    June 2020
  17. RODRIGUEZ-GANDIA MA, Lopez-Hervas P, Tellez L, Gajate L, et al
    Successful urgent liver transplant due to fulminant autoimmune hepatitis during the height of the COVID-19 pandemic in Spain.
    Gastroenterol Hepatol. 2020 Jun 11. pii: S0210-5705(20)30213.
    PubMed    


    April 2020
  18. GUZMAN RAMOS MI, Manzano-Garcia M, Robustillo-Cortes MLA, Pineda JA, et al
    Effect on the adherence to concomitant medications after initiation of treatment with direct-acting antiviral agents against hepatitis C virus.
    Gastroenterol Hepatol. 2020 Apr 9. pii: S0210-5705(20)30071.
    PubMed     Abstract available


    March 2020
  19. GONI ESARTE S, Juanbeltz R, Zozaya JM, Uriz JI, et al
    Modification of liver fibrosis, glucose and lipid profile after hepatitis C virus clearance with direct-acting antiviral agents.
    Gastroenterol Hepatol. 2020 Mar 16. pii: S0210-5705(20)30041.
    PubMed     Abstract available


  20. MAS ORDEIG A, Bordon Garcia N
    Hepatotoxicity caused by Garcinia cambogia.
    Gastroenterol Hepatol. 2020;43:134-135.
    PubMed    


    February 2020
  21. FERNANDEZ I, Pascasio JM, Colmenero J
    Prophylaxis and treatment in liver transplantation. VII Consensus Document of the Spanish Society of Liver Transplantation.
    Gastroenterol Hepatol. 2020 Feb 21. pii: S0210-5705(20)30015.
    PubMed     Abstract available


    January 2020
  22. SASTRE L, Garcia-Lopez M, Perez-Del-Pulgar S, Lens S, et al
    The challenge of chronic hepatitis E in liver transplant recipients: Failure of sofosbuvir plus ribavirin therapy.
    Gastroenterol Hepatol. 2020 Jan 2. pii: S0210-5705(19)30140.
    PubMed    


    October 2019
  23. CRESPO J, Albillos A, Buti M, Calleja JL, et al
    Elimination of hepatitis C. Positioning document of the Spanish Association for the Study of the Liver (AEEH).
    Gastroenterol Hepatol. 2019 Oct 5. pii: S0210-5705(19)30208.
    PubMed     Abstract available


  24. HERNAEZ-ALSINA T, Caballol-Oliva B, Diaz-Gonzalez A, Guedes-Leal C, et al
    Risk of recurrence of hepatocellular carcinoma in patients treated with interferon-free antivirals.
    Gastroenterol Hepatol. 2019;42:502-511.
    PubMed     Abstract available


    September 2019
  25. LLOVET LP, Sciarrone S, Rodriguez-Tajes S, Montironi C, et al
    Ductular reaction and hepatocyte ballooning identify patients with fibrosing cholestatic hepatitits after liver transplantation.
    Gastroenterol Hepatol. 2019 Sep 5. pii: S0210-5705(19)30173.
    PubMed     Abstract available


    August 2019
  26. SICRAS MAINAR A, Navarro Artieda R, Hernandez I, Morillo R, et al
    Prevalence of the potential drug-drug interactions between pangenotypic direct-acting antivirals and the concomitant medications associated with patients with chronic hepatitis C virus infection in Spain.
    Gastroenterol Hepatol. 2019 Aug 23. pii: S0210-5705(19)30138.
    PubMed     Abstract available


  27. GOTOR DELSO J, Espina Cadena S, Garcia Camara P, Sanz Segura P, et al
    Zieve's syndrome, an underdiagnosed entity.
    Gastroenterol Hepatol. 2019;42:431-432.
    PubMed    


    July 2019
  28. LAGUNO M, Martinez-Rebollar M, de la Mora L, Perez-Del-Pulgar S, et al
    Barriers to hepatitis C virus elimination in MSM living with HIV: The high risk of reinfection. Case study: A patient with 6 episodes.
    Gastroenterol Hepatol. 2019 Jul 16. pii: S0210-5705(19)30132.
    PubMed    


  29. LOPEZ ZUNIGA MA, Prieto Moreno M, de Jesus S, Lopez Ruz MA, et al
    Response to Retreatment of hepatitis C virus Patients in whom Direct-Acting Antivirals have Failed.
    Gastroenterol Hepatol. 2019 Jul 15. pii: S0210-5705(19)30127.
    PubMed    


    June 2019
  30. YEBRA CARMONA J, Jaquotot Herranz M, Tavecchia M, Castillo Grau P, et al
    Syndrome of inappropriate antidiuretic hormone secretion following transarterial chemoembolisation of hepatocellular carcinoma.
    Gastroenterol Hepatol. 2019;42:397-398.
    PubMed    


    April 2019
  31. REVUELTO ARTIGAS T, Betriu Bars A, Zaragoza Velasco N, Gomez Arbones X, et al
    Antiviral treatment does not improve subclinical atheromatosis in patients with chronic hepatitis caused by hepatitis C virus.
    Gastroenterol Hepatol. 2019 Apr 2. pii: S0210-5705(19)30049.
    PubMed     Abstract available


    February 2019
  32. YU K, Du Z, Li Q, Cheng Q, et al
    Comparison of non-invasive models for predicting liver damage in chronic hepatitis B patients.
    Gastroenterol Hepatol. 2019 Feb 13. pii: S0210-5705(19)30025.
    PubMed     Abstract available


    November 2018
  33. ALSIUS M, Ferri MJ, Buxo M, Lopez C, et al
    Autoantibodies to cytoplasmic rods and rings in patients with hepatitis C virus infection treated with direct-acting antivirals: The role of prior treatment with interferon plus ribavirin.
    Gastroenterol Hepatol. 2018 Nov 13. pii: S0210-5705(18)30249.
    PubMed     Abstract available


    October 2018
  34. MADUELL F, Belmar L, Ugalde J, Laguno M, et al
    Elimination of hepatitis C virus infection from a hemodialysis unit and impact of treatment on the control of anemia.
    Gastroenterol Hepatol. 2018 Oct 4. pii: S0210-5705(18)30252.
    PubMed     Abstract available


    September 2018
  35. CALLEJA JL, Macias J, Forns X, Garcia F, et al
    Guidelines on treatment of hepatitis C virus infection. Spanish Association for the Study of the Liver (AEEH).
    Gastroenterol Hepatol. 2018 Sep 27. pii: S0210-5705(18)30217.
    PubMed    


    July 2018
  36. MIRANDA-BAUTISTA J, Menchen L
    Adalimumab-induced autoimmune hepatitis in a patient with Crohn's disease.
    Gastroenterol Hepatol. 2018 Jul 17. pii: S0210-5705(18)30191.
    PubMed    


  37. MARTINEZ CASAS OY, Diaz Ramirez GS, Marin Zuluaga JI, Santos O, et al
    Autoimmune hepatitis - primary biliary cholangitis overlap syndrome. Long-term outcomes of a retrospective cohort in a university hospital.
    Gastroenterol Hepatol. 2018 Jul 12. pii: S0210-5705(18)30150.
    PubMed     Abstract available


  38. ARIZAGA G, Castiella A, Zubiaurre L, Zapata E, et al
    Autoimmune hepatitis and coeliac disease. Simultaneous onset of both diseases.
    Gastroenterol Hepatol. 2018 Jul 5. pii: S0210-5705(18)30155.
    PubMed    


    June 2018
  39. MIRANDA J, Valenzuela M, Hurtado C, Vera DB, et al
    Decrease in seroprevalence of hepatitis A virus in Santiago, Chile: A decade-long comparison.
    Gastroenterol Hepatol. 2018 Jun 2. pii: S0210-5705(18)30127.
    PubMed    


    May 2018
  40. RIOS LEON R, Rodriguez Gandia MA, Rodriguez de Santiago E, Sanchez Rodriguez E, et al
    Treatment with ribavirin of acute hepatitis and severe renal damage in an immunocompetent patient.
    Gastroenterol Hepatol. 2018 May 11. pii: S0210-5705(18)30061.
    PubMed    


    April 2018
  41. PEDROSA M, Nogales S, Vergara M, Miquel M, et al
    Reactivation of peritoneal and pleural tuberculosis during hepatitis C treatment with direct-acting antivirals.
    Gastroenterol Hepatol. 2018 Apr 14. pii: S0210-5705(18)30087.
    PubMed    


    January 2018
  42. SOLE C, Sola E
    Update on acute-on-chronic liver failure.
    Gastroenterol Hepatol. 2018;41:43-53.
    PubMed     Abstract available


    December 2017
  43. SICRAS-MAINAR A, Navarro-Artieda R, Saez-Zafra M
    Comorbidity, concomitant medication, use of resources and healthcare costs associated with chronic hepatitis C virus carriers in Spain.
    Gastroenterol Hepatol. 2017 Dec 26. pii: S0210-5705(17)30249.
    PubMed     Abstract available


  44. GUARDIOLA-AREVALO A, Gomez Rodriguez R, Romero Gutierrez M, Gomez Moreno AZ, et al
    Hepatitis B virus e antigen-negative chronic infection. Treatment based on glutamic pyruvic transaminase and hepatitis B virus deoxyribonucleic acid cut-off values.
    Gastroenterol Hepatol. 2017 Dec 23. pii: S0210-5705(17)30243.
    PubMed     Abstract available


    November 2017
  45. ACERO FERNANDEZ D, Ferri Iglesias MJ, Buxo Pujolras M, Lopez Nunez C, et al
    Changes in the epidemiology and distribution of the hepatitis C virus genotypes in North-Eastern Spain over the last 35 years.
    Gastroenterol Hepatol. 2017 Nov 14. pii: S0210-5705(17)30224.
    PubMed     Abstract available


  46. MONTESERIN L, Jimenez M, Linares P, Rodriguez-Martin L, et al
    Acute hepatitis secondary to high-dose intravenous methylprednisolone.
    Gastroenterol Hepatol. 2017 Nov 10. pii: S0210-5705(17)30221.
    PubMed    


  47. DIAZ-RAMIREZ GS, Marin-Zuluaga JI, Donado-Gomez JH, Munoz-Maya O, et al
    Characterization of patients with autoimmune hepatitis at an university hospital in Medellin-Colombia: cohort study.
    Gastroenterol Hepatol. 2017 Nov 7. pii: S0210-5705(17)30222.
    PubMed     Abstract available


    October 2017
  48. HONRUBIA-LOPEZ R, Rueda-Garcia JL, Burgos-Garcia A, Fernandez-Martos R, et al
    Acute hepatitis as a manifestation of secondary syphilis.
    Gastroenterol Hepatol. 2017 Oct 17. pii: S0210-5705(17)30203.
    PubMed    


    July 2017
  49. MAS A
    Contributions to our understanding of fulminant hepatitis from the Liver ICU of Hospital Clinic Barcelona: Historical review.
    Gastroenterol Hepatol. 2017 Jul 17. pii: S0210-5705(17)30149.
    PubMed    


  50. ANTON MD, Polanco A, Ferrando I, Latorre P, et al
    Hepatitis B reactivation in a patient with chronic hepatitis C treated with direct-acting antivirals.
    Gastroenterol Hepatol. 2017 Jul 17. pii: S0210-5705(17)30150.
    PubMed    


    June 2017
  51. SANCHEZ M, Castiella A, Zapata E, Zubiaurre L, et al
    Autoimmune Hepatitis (Immune-Mediated Liver Injury) Induced By Rosuvastatin.
    Gastroenterol Hepatol. 2017 Jun 24. pii: S0210-5705(17)30133.
    PubMed    


  52. LLERENA S, Cabezas J, Iruzubieta P, Crespo J, et al
    Resistance to hepatitis C virus. Implications and therapeutic options.
    Gastroenterol Hepatol. 2017 Jun 21. pii: S0210-5705(17)30125.
    PubMed     Abstract available


  53. TURNES J, Dominguez-Hernandez R, Casado MA
    Cost-effectiveness analysis of two treatment strategies for chronic hepatitis C before and after access to direct-acting antivirals in Spain.
    Gastroenterol Hepatol. 2017 Jun 20. pii: S0210-5705(17)30124.
    PubMed     Abstract available


    May 2017
  54. TORRES VARGAS C, Martinez Herreros A, Sacristan Terroba B
    Weil's disease and acute multifactorial hepatitis. About a case.
    Gastroenterol Hepatol. 2017 May 18. pii: S0210-5705(17)30104.
    PubMed    


    January 2017
  55. ARAOS-BAERISWYL E, Moll-Manzur C
    Renal aspergillosis after liver transplant: Report of an unusual case.
    Gastroenterol Hepatol. 2017 Jan 11. pii: S0210-5705(16)30198.
    PubMed    


    November 2015
  56. LLOVET LP, Rodriguez-Tajes S, Londono MC
    [Treatment of hepatitis C before and after liver transplantation].
    Gastroenterol Hepatol. 2015 Nov 4. pii: S0210-5705(15)00225.
    PubMed     Abstract available


    August 2015
  57. SENOSIAIN C, Gonzalez-Tallon A A, Lopez-Sanroman A, Mateos ML, et al
    Hepatitis E seroprevalence in inflammatory bowel disease.
    Gastroenterol Hepatol. 2015 Aug 6. pii: S0210-5705(15)00148.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Hepatitis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: